Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Frizzled 9 ELISA Kit (AC3325)
Cat.#: ASET-1914
Specifications
Description Human Frizzled 9 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Frizzled 9 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.87 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 200-3200 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1378 Human GALP ELISA Kit (AC2789) Quantitative inquiry ASET-2383 Human VIP ELISA Kit (AC3794) Quantitative inquiry ASET-1054 Human LCN1 ELISA Kit (AC2465) Quantitative inquiry ASET-1155 Human SOX9 ELISA Kit (AC2566) Quantitative inquiry ASET-2393 Mouse Wnt5a ELISA Kit (AC3804) Quantitative inquiry ASET-1995 Human NRG4 ELISA Kit (AC3406) Quantitative inquiry ASET-1773 Mouse APPBP2 ELISA Kit (AC3184) Quantitative inquiry ASET-2509 Human Acetylcholinesterase ELISA Kit (AC3920) Quantitative inquiry ASET-1882 Human ERK1 ELISA Kit (AC3293) Quantitative inquiry ASET-1398 Human nNOS (neuronal) ELISA Kit (AC2809) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket